|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00911 QIANHAI HEALTH
Nominal 
0.270 -0.025 (-8.475%) | 2025/12 - Final HKD(K$) | %Chg (Compare to Final) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Turnover | 677,121 | 30.291% | 519,699 | 961,291 | 1,961,704 | 283,398 |
| Cost of Sales | (653,523) | 33.364% | (490,029) | (996,894) | (1,885,222) | (267,360) |
| Gross Profit | 23,598 | -20.465% | 29,670 | (35,603) | 76,482 | 16,038 |
| 2025/12 - Final HKD(K$) | %Chg (Compare to Final) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 5,943 | 353.318% | 1,311 | (52,705) | (233,703) | (888) | |
| Taxation | (2) | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 5,941 | 353.166% | 1,311 | (52,705) | (233,703) | (888) | |
| 2025/12 - Final HKD(K$) | %Chg (Compare to Final) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Finance Costs / (Income) | (446) | 102.727% | (220) | (26) | (66) | 389 |
| Depreciation & Amortisation | 1,519 | -36.708% | 2,400 | 2,433 | 2,434 | 2,436 |
| Directors' Emoluments | -- | -- | 1,678 | 1,335 | 2,649 | 4,268 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Qualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 3.510 | 355.844% | 0.770 | -31.100 | -137.900 | -0.500 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.025 | 0.005 | (0.031) | (0.026) |
| NBV per share ($) | 2.309 | -- | 2.275 | 2.267 | 2.577 | 3.957231 |
| Remarks: | Real time quote last updated: 20/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 5,941 |
| %Change | 353.166% |
| EPS / (LPS) | HKD 0.035 |
| NBV Per Share ($) | HKD 2.309 |